1. | RetirementPlan1 | |
2. | researcher17 | |
3. | DontGiveMeLip | |
4. | candiskingdom | |
5. | kitcaitrn |
1. | RetirementPlan1 | |
2. | researcher17 | |
3. | DontGiveMeLip | |
4. | candiskingdom | |
5. | kitcaitrn |
1. | researcher17 01/31/2018 Aldeyra Therapeutics Announces First Patient Enrolled in Dry Eye Disease Phase 2b Clinical Trial |
2. | researcher17 04/24/2018 Enrolled the first patien |
3. | RetirementPlan1 01/26/2018 Recent $ALDX : - Seaport Global Securities initiates as a buy |
4. | RetirementPlan1 10/01/2017 OCT investor day should be back near to HOY.. Market cap $7 x 18m < $150M To discuss new clinical findings from its clinical trials in allergic conjunctivitis and dry eye disease {Link} |
5. | RetirementPlan1 09/14/2017 Too late to get in? |
6. | DontGiveMeLip 10/01/2017 The classic "protect patents by buying out" {Link} |